Literature DB >> 17290036

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Ruth L Coleman1, Richard J Stevens, Ravi Retnakaran, Rury R Holman.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17290036     DOI: 10.2337/dc06-1358

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  62 in total

1.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

2.  High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study.

Authors:  Hilal Maradit Kremers; Cynthia S Crowson; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2008-08

Review 3.  Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Authors:  Mohammed E Al-Sofiani; Robert Derenbecker; Michael Quartuccio; Rita R Kalyani
Journal:  Curr Diab Rep       Date:  2019-09-23       Impact factor: 4.810

Review 4.  Subclinical cardiovascular disease assessment in persons with diabetes.

Authors:  Haider Javed Warraich; Khurram Nasir
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

Review 5.  Cardiovascular risk assessment--from individual risk prediction to estimation of global risk and change in risk in the population.

Authors:  John A Batsis; Francisco Lopez-Jimenez
Journal:  BMC Med       Date:  2010-05-25       Impact factor: 8.775

6.  Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.

Authors:  Shaista Malik; Yanglu Zhao; Matthew Budoff; Khurram Nasir; Roger S Blumenthal; Alain G Bertoni; Nathan D Wong
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

7.  Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.

Authors:  H C Price; R L Coleman; R J Stevens; R R Holman
Journal:  Diabetologia       Date:  2008-12-02       Impact factor: 10.122

8.  Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.

Authors:  Maximilian von Eynatten; Dan Liu; Cornelia Hock; Dimitrios Oikonomou; Marcus Baumann; Bruno Allolio; Grigorios Korosoglou; Michael Morcos; Valentina Campean; Kerstin Amann; Jens Lutz; Uwe Heemann; Peter P Nawroth; Angelika Bierhaus; Per M Humpert
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

9.  Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.

Authors:  Amber A W A van der Heijden; Monica M Ortegon; Louis W Niessen; Giel Nijpels; Jacqueline M Dekker
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

Review 10.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.